Independent Advisor Alliance’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,441
Closed -$342K 917
2019
Q3
$342K Sell
3,441
-24
-0.7% -$2.28K 0.04% 310
2019
Q2
$320K Sell
3,465
-90
-3% -$8.55K 0.05% 285
2019
Q1
$335K Sell
3,555
-4,273
-55% -$374K 0.05% 292
2018
Q4
$502K Sell
7,828
-4,132
-35% -$305K 0.09% 195
2018
Q3
$904K Buy
11,960
+2,850
+31% +$252K 0.16% 136
2018
Q2
$572K Buy
9,110
+944
+12% +$78.4K 0.12% 172
2018
Q1
$712K Sell
8,166
-823
-9% -$79K 0.16% 153
2017
Q4
$936K Buy
8,989
+1,727
+24% +$195K 0.21% 122
2017
Q3
$1.03M Buy
7,262
+2,927
+68% +$399K 0.28% 92
2017
Q2
$572K Sell
4,335
-1,668
-28% -$204K 0.18% 131
2017
Q1
$745K Buy
6,003
+1,899
+46% +$227K 0.12% 196
2016
Q4
$462K Buy
+4,104
New +$457K 0.2% 114

Other funds holding CELG

Independent Advisor Alliance's CELG Position: Q4 2019 in Review

Independent Advisor Alliance sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,441 shares — an estimated $342K sold.

Independent Advisor Alliance first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $1.03M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Independent Advisor Alliance reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Independent Advisor Alliance sold 3,441 Celgene Corp shares in Q4 2019, an estimated $342K.
  • Independent Advisor Alliance first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Independent Advisor Alliance's Celgene Corp position peaked at $1.03M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Independent Advisor Alliance's 13F filing for Q4 2019, filed 7 Feb 2020.